Statements (45)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:blockade
|
gptkbp:brand |
gptkb:Astra_Zeneca
gptkb:Toprol-XL |
gptkbp:category |
gptkb:C
|
gptkbp:chemical_formula |
C15 H25 NO3
|
gptkbp:class |
selective beta-1 adrenergic antagonist
aryloxypropanolamine |
gptkbp:contraindication |
gptkb:asthma
heart block severe bradycardia |
gptkbp:dosage_form |
200 mg once daily
100 mg once daily 400 mg once daily 50 mg once daily |
gptkbp:excretion |
urine
|
gptkbp:form |
extended-release tablet
solution for injection |
gptkbp:formulation |
sustained-release
immediate-release |
gptkbp:healthcare |
gptkb:1992
|
https://www.w3.org/2000/01/rdf-schema#label |
Metoprolol Succinate
|
gptkbp:indication |
anxiety
thyrotoxicosis post-myocardial infarction migraine prophylaxis |
gptkbp:interacts_with |
gptkb:digoxin
MAO inhibitors calcium channel blockers |
gptkbp:lifespan |
3 to 7 hours
|
gptkbp:metabolism |
liver
|
gptkbp:route_of_administration |
oral
intravenous |
gptkbp:side_effect |
gptkb:depression
dizziness fatigue bradycardia |
gptkbp:trade |
gptkb:Betaloc
gptkb:Lopressor |
gptkbp:used_for |
hypertension
heart failure arrhythmias angina pectoris |
gptkbp:weight |
265.37 g/mol
|
gptkbp:bfsParent |
gptkb:metoprolol
|
gptkbp:bfsLayer |
5
|